Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New drug/device borderline guideline due out any day now, says Commission

This article was originally published in Clinica

Executive Summary

The European Commission told Clinica on June 22 that it is finalising the revised drug/device borderline guideline, meddev 2.1.3, and that this document should be published by the end of June. This is a complex area and given the rapid technological evolution in this area, there is much need for this update. The last guideline to be published by the Commission, 16 pages long, is dated July 2001.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT043604

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel